Clinical trial
Abatacept and Infliximab in Combination With Methotrexate in Subjects With…
NCT00095147 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00095147 |
|---|---|
| Title | Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis |
| Official title | A Phase IIIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Comparative Study of Abatacept or Infliximab in Combination With Methotrexate in Controlling Disease Activity in Subjects With Rheumatoid Arthritis Having an Inadequate Clinical Response to Methotrexate |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Abatacept (ABA) + Methotrexate (MTX), double-blind (DB), Infliximab (INF) + MTX, DB, Placebo (PLA) + MTX, PLA + MTX switched to ABA+ MTX, ABA, open-label (OL) |
| Enrollment | 431 |
| Start date | Feb 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Nov 2, 2004 |
| Last update posted | Mar 24, 2015 |
| Countries | Argentina, Australia, Brazil, Canada, Czechia, Denmark, Mexico, Peru, Poland, Puerto Rico, Russia, South Africa and 5 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: